Tag: cannabigerol

Study: Cannabigerol May Treat Neuroinflammation and Oxidative Stress

According to a new study published by the International Journal of Molecular Sciences, the cannabis compound cannabigerol “may be a potential treatment against neuroinflammation and oxidative stress.” “Inflammation and oxidative stress play main roles in neurodegeneration”, states the study’s abstract. “Interestingly, different natural compounds may be able to exert neuroprotective actions against inflammation and oxidative stress, …

Continue reading

Study: Cannabigerol Effective At Stimulating Appetite

The cannabis compound cannabigerol (CBG) is effective at stimulating appetite without any negative side effects, according to a new study published by the journal Psychopharmacology; it was epublished ahead of print by the U.S. National Institute of Health. The study was published shortly after a separate study (also published by Psychopharmacology) which found that two …

Continue reading

Study: Cannabigerol May Prevent Colon Cancer

A new study published by the Oxford journal Carcinogenesis, and published online by the U.S. National Institute of Health, has found that the cannabis compound cannabigerol can prevent the progression of cancer cells formed in the colon. “Cannabigerol (CBG) is a safe non-psychotropic Cannabis-derived cannabinoid which interacts with specific targets involved in carcinogenesis [the creation …

Continue reading

New Study Finds Cannabis May Provide Treatment for Skin Diseases

A new study, recently published online in the British Journal of Pharmacology, details how cannabinoids can play a role in the treatment of skin diseases. Researchers looked at the impact of phytocannabinoids (plant-derived cannabinoids, rather than synthetic counterparts) on epigenetic regulation of skin differentiation genes. The study found that both cannabidiol (CBD) and cannabigerol (CBG), “significantly …

Continue reading